ELIQUIS

Swiss trademark · 569602 · Word mark · In force

Register entry

Registration number
569602
Application number
64235/2007
Status
In force
Type
Word mark
Filed
Dec 14, 2007
Registered
Mar 26, 2008
Published
Apr 9, 2008
Protected until
Dec 14, 2027
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Prävention und Behandlung von kardiovaskulären Krankheiten, ausgenommen diagnostische Produkte für den medizinischen, veterinärmedizinischen und wissenschaftlichen Gebrauch.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Feb 1, 2021

    Holder’s address changed

    Owner
    Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen → Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen

    Published in Swissreg on 01.02.2021

  3. Aug 16, 2017

    Renewed

    Published in Swissreg on 16.08.2017

  4. Jul 22, 2016

    Transferred

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen

    Published in Swissreg on 22.07.2016

  5. Apr 29, 2011

    Transferred

    Owner
    Pfizer Products Inc., Eastern Point Road, CT 06340 Groton, USA → Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA

    Published in Swissreg on 29.04.2011

  6. Apr 9, 2008

    Registered

    Published in the SOGC no. 68 of 09.04.2008

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.